Abstract
Editor—Mayne et al reported evidence of benefit from routine antenatal administration of anti-D immunoglobulin to primigravid women who are RhD negative.1 It has been proposed that this policy be adopted...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
